OverviewChartProfileKey statisticsFinancialsNews
Derivatives
TraderScreen

ABBVIE INC. DL-,01/  US00287Y1091  /

Lang & Schwarz
2024-04-19  10:19:10 AM Chg. +0.240 Volume Bid10:19:10 AM Ask10:19:10 AM Market Capitalization Dividend Y. P/E Ratio
154.420EUR +0.16% -
Turnover: -		 154.420Bid Size: - 155.160Ask Size: - 273.28 bill.EUR - -
GlobeNewswire 04-18 Cerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial fo...
GlobeNewswire 04-17 Royalty Pharma Declares Second Quarter 2024 Dividend
GlobeNewswire 04-16 Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara®...
GlobeNewswire 04-16 OSE Immunotherapeutics’ Global License to Develop a Novel Monoclonal Antibody for the Treatment of C...
GlobeNewswire 04-16 Nxera Pharma Notes Successful Development Progress of Partnered Schizophrenia Candidate NBI-1117568
GlobeNewswire 04-15 Ocular Therapeutix™ Executive Chairman Pravin U. Dugel, MD Becomes President and CEO Antony Mattessi...
Newsfile Corp 04-12 Allergan Aesthetics and University Lab Partners Announce the Golden Ticket Pitch Competition to Acce...
GlobeNewswire 04-09 STOCKHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger – DOMA, LABP, FUSN, ...
GlobeNewswire 04-09 Enliven Therapeutics Appoints Dr. Lori Kunkel to Board of Directors
GlobeNewswire 04-08 Coherus Presents Preclinical Data for CHS-1000, a Novel Anti-ILT4 Antibody, at the 2024 AACR Annual ...
GlobeNewswire 04-08 CytomX Therapeutics Announces First Patient Dosed with CX-2051, a Conditionally Activated EpCAM-Dire...
GlobeNewswire 04-06 Ocular Therapeutix™ Announces Positive Phase 2 PAXTRAVA™ Glaucoma Data at the American Society of Ca...
GlobeNewswire 04-03 Sig Kirk Joins Assertio Board of Directors
GlobeNewswire 04-02 Sight Sciences Announces the Results of the Three-Year Prospective GEMINI Trial and the Cross-Over P...
GlobeNewswire 04-02 Abivax reports 2023 financial results and operational update
GlobeNewswire 04-02 OSE Immunotherapeutics Announces Peer-Reviewed Publication on Novel Myeloid Immune Checkpoint CLEC-1...
GlobeNewswire 04-01 SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates ADTH, LABP, FUSN
GlobeNewswire 04-01 BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AdTheorent ...
GlobeNewswire 04-01 NEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an Increase of 99.7% Year-Over-Year
GlobeNewswire 03-28 Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of Directors
GlobeNewswire 03-27 Kuehn Law Encourages LABP, WRK, KAMN and TGAN Investors to Contact Law Firm
GlobeNewswire 03-27 SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates DRQ, FUSN, LABP, FXNC
GlobeNewswire 03-25 BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Agiliti, In...
GlobeNewswire 03-25 Professional Diversity Network (PDN) Hosts Successful Virtual Career Fair for Women’s History Month
GlobeNewswire 03-25 AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmu...